Successful Treatment of Hypersplenism in Wilson's Disease by Partial Splenic Embolization
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Investigative Surgery"
DOI: 10.1080/08941939.2016.1278058
Abstract: ABSTRACT Aim: Hypersplenism can occur in patients with Wilson's disease (WD). Surgical splenectomy is a conventional treatment for this condition; however, emotional and neurological deterioration may follow splenectomy. In recent years, partial splenic embolization (PSE)… read more here.
Keywords: treatment; hypersplenism; treatment hypersplenism; splenic embolization ... See more keywords
Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism
Sign Up to like & getrecommendations! Published in 2021 at "Medicine"
DOI: 10.1097/md.0000000000026441
Abstract: Abstract This study retrospectively studied transarterial chemoembolization (TACE) combined with partial splenic embolization (PSE) in the treatment of hepatocellular carcinoma (HCC) with severe hypersplenism. Seventy patients with HCC in Barcelona Clinic Liver Cancer (BCLC) stage… read more here.
Keywords: pse; pse group; hypersplenism; partial splenic ... See more keywords
Analysis of predictors after partial splenic embolization for thrombocytopenia with liver cirrhosis
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030985
Abstract: Blood transfusion, splenectomy, and partial splenic embolization (PSE) are generally performed for thrombocytopenia in patients with cirrhosis. Recently, thrombopoietin (TPO) agonists have become available, and investigations of patients who would benefit from them are necessary.… read more here.
Keywords: liver cirrhosis; partial splenic; splenic embolization; thrombocytopenia ... See more keywords
Partial Splenic Embolization for the Management of Severe Refractory Thrombocytopenia in Antiphospholipid Syndrome: A Case Report and Literature Review
Sign Up to like & getrecommendations! Published in 2022 at "Vascular and Endovascular Surgery"
DOI: 10.1177/15385744211072682
Abstract: Antiphospholipid syndrome is an autoimmune condition characterized by arteriovenous thromboembolic events. Thrombocytopenia is a common finding among these patients and is typically of mild severity not requiring any treatment. However, severe cases of thrombocytopenia should… read more here.
Keywords: refractory; partial splenic; splenic embolization; antiphospholipid syndrome ... See more keywords
Partial splenic embolization in chemotherapy-induced thrombocytopenia: A retrospective analysis with long term follow-up.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e21654
Abstract: e21654Background: Chemotherapy-induced thrombocytopenia (CIT) may result in a chemotherapy (CT) dose delay or reduction, thus affecting dose density and intensity. Historically, partial splenic emb... read more here.
Keywords: chemotherapy; embolization chemotherapy; induced thrombocytopenia; splenic embolization ... See more keywords
Partial Splenic Embolization for Lenvatinib Therapy-associated Thrombocytopenia Among Patients With Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "AntiCancer Research"
DOI: 10.21873/anticanres.13909
Abstract: Background: Lenvatinib, a newly developed oral multi-tyrosine kinase inhibitor, has amazing potential in the multidisciplinary treatment of advanced or metastatic hepatocellular carcinoma. Thrombocytopenia is a serious adverse event that causes drug dose reduction or withdrawal.… read more here.
Keywords: lenvatinib therapy; partial splenic; splenic embolization;
Is Partial Splenic Embolization a Good Option to Prevent Cirrhotic Complications in the Long Term?
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Korean Medical Science"
DOI: 10.3346/jkms.2019.34.e209
Abstract: https://jkms.org Kim et al.1 recently reported that partial splenic embolization (PSE) had good safety and efficacy to increase platelet counts in hepatocellular carcinoma (HCC) patients with thrombocytopenia who underwent trans-arterial chemoembolization (TACE). In this study,… read more here.
Keywords: pse; group; pse group; splenic embolization ... See more keywords